 | Up a level |
2022
Heitz, F., Ataseven, B., Moubarak, M., Staniczok, C., Schmutzler, R., Schameis, R., Heikaus, S., Concin, N., Riehm, K., Denkert, C. and Harter, P. (2022). HRD Testing and BRCA1/2 Germline Testing in Routine Clinical Practice in Patients with primary Ovarian Cancer. Geburtshilfe Frauenheilkd., 82 (10). S. E86 - 1. STUTTGART: GEORG THIEME VERLAG KG. ISSN 1438-8804
2016
Heimbach, A., Hauke, J., Richters, L., Kroeber, S., Altmueller, J., Becker, C., Thiele, H., Nuernberg, P., Bluemcke, B., Neidhardt, G., Riehm, K., Schmutzler, R. and Hahnen, E. (2016). TruRisk (R) based next-generation sequencing reveals a high prevalence of deleterious ATM mutations in BRCA1/2-negative breast and ovarian cancer families. Oncol. Res. Treat., 39. S. 52 - 53. BASEL: KARGER. ISSN 2296-5262